DEXCOM, INC. Operating Expenses
DEXCOM, INC. (DXCM) reported Operating Expenses of $511.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-30
- DEXCOM, INC. operating expenses for the quarter ending 2026-06-30 was $511.70M, a 7.45% increase year-over-year.
- DEXCOM, INC. operating expenses for the quarter ending 2026-03-31 was $495.00M, a 8.72% increase year-over-year.
- DEXCOM, INC. operating expenses for the quarter ending 2025-12-31 was $469.70M, a 0.60% increase year-over-year.
- DEXCOM, INC. operating expenses for the quarter ending 2025-09-30 was $488.90M, a 10.66% increase year-over-year.
- DEXCOM, INC. operating expenses for fiscal 2025 was $1.89B, a 2.82% increase from fiscal 2024.
- DEXCOM, INC. operating expenses for fiscal 2024 was $1.84B, a 8.69% increase from fiscal 2023.
- DEXCOM, INC. operating expenses for fiscal 2023 was $1.69B, a 13.36% increase from fiscal 2022.
- DEXCOM, INC. operating expenses for fiscal 2022 was $1.49B, a 5.46% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $511.70M 10-Q · filed 2026-07-30 | $1.01B 10-Q · filed 2026-07-30 | $1.48B derived: sum of 3 quarters · filed 2026-07-30 | $1.97B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $495.00M 10-Q · filed 2026-04-30 | $964.70M derived: sum of 2 quarters · filed 2026-04-30 | $1.45B derived: sum of 3 quarters · filed 2026-04-30 | $1.93B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $469.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $958.60M derived: sum of 2 quarters · filed 2026-02-12 | $1.43B derived: sum of 3 quarters · filed 2026-07-30 | $1.89B 10-K · filed 2026-02-12 | |||
| 2025-09-30 | $488.90M 10-Q · filed 2025-10-30 | $965.10M derived: sum of 2 quarters · filed 2026-07-30 | $1.42B 10-Q · filed 2025-10-30 | $1.89B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $476.20M 10-Q · filed 2026-07-30 | $931.50M 10-Q · filed 2026-07-30 | $1.40B derived: sum of 3 quarters · filed 2026-07-30 | $1.84B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $455.30M 10-Q · filed 2026-04-30 | $922.20M derived: sum of 2 quarters · filed 2026-04-30 | $1.36B derived: sum of 3 quarters · filed 2026-04-30 | $1.83B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $466.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $908.70M derived: sum of 2 quarters · filed 2026-02-12 | $1.38B derived: sum of 3 quarters · filed 2026-02-12 | $1.84B 10-K · filed 2026-02-12 | |||
| 2024-09-30 | $441.80M 10-Q · filed 2025-10-30 | $910.50M derived: sum of 2 quarters · filed 2025-10-30 | $1.37B 10-Q · filed 2025-10-30 | $1.81B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | $468.70M 10-Q · filed 2025-07-30 | $929.50M 10-Q · filed 2025-07-30 | $1.37B derived: sum of 3 quarters · filed 2026-02-12 | $1.79B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $460.80M 10-Q · filed 2025-05-01 | $900.50M derived: sum of 2 quarters · filed 2026-02-12 | $1.32B derived: sum of 3 quarters · filed 2026-02-12 | $1.74B derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $439.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $857.50M derived: sum of 2 quarters · filed 2026-02-12 | $1.28B derived: sum of 3 quarters · filed 2026-02-12 | $1.69B 10-K · filed 2026-02-12 | |||
| 2023-09-30 | $417.80M 10-Q · filed 2024-10-24 | $836.10M derived: sum of 2 quarters · filed 2024-10-24 | $1.25B 10-Q · filed 2024-10-24 | $1.67B derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-06-30 | $418.30M 10-Q · filed 2024-07-25 | $833.70M 10-Q · filed 2024-07-25 | $1.25B derived: sum of 3 quarters · filed 2025-02-18 | $1.60B derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-03-31 | $415.40M 10-Q · filed 2024-04-25 | $831.30M derived: sum of 2 quarters · filed 2025-02-18 | $1.18B derived: sum of 3 quarters · filed 2025-02-18 | $1.55B derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2022-12-31 | $415.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $762.60M derived: sum of 2 quarters · filed 2025-02-18 | $1.14B derived: sum of 3 quarters · filed 2025-02-18 | $1.49B 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $346.70M 10-Q · filed 2023-10-26 | $719.20M derived: sum of 2 quarters · filed 2023-10-26 | $1.08B 10-Q · filed 2023-10-26 | $1.55B derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-06-30 | $372.50M 10-Q · filed 2023-07-27 | $729.30M 10-Q · filed 2023-07-27 | $1.20B derived: sum of 3 quarters · filed 2024-02-08 | $1.53B derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-03-31 | $356.80M 10-Q · filed 2023-04-27 | $828.80M derived: sum of 2 quarters · filed 2024-02-08 | $1.16B derived: sum of 3 quarters · filed 2024-02-08 | $1.47B derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2021-12-31 | $472.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $800.60M derived: sum of 2 quarters · filed 2024-02-08 | $1.12B derived: sum of 3 quarters · filed 2024-02-08 | $1.41B 10-K · filed 2024-02-08 | |||
| 2021-09-30 | $328.60M 10-Q · filed 2022-10-27 | $644.70M derived: sum of 2 quarters · filed 2022-10-27 | $942.70M 10-Q · filed 2022-10-27 | $1.24B derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-06-30 | $316.10M 10-Q · filed 2022-07-28 | $614.10M 10-Q · filed 2022-07-28 | $909.20M derived: sum of 3 quarters · filed 2023-02-09 | $1.16B derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-03-31 | $298.00M 10-Q · filed 2022-04-28 | $593.10M derived: sum of 2 quarters · filed 2023-02-09 | $839.40M derived: sum of 3 quarters · filed 2023-02-09 | $1.06B derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | $295.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $541.40M derived: sum of 2 quarters · filed 2023-02-09 | $757.70M derived: sum of 3 quarters · filed 2023-02-09 | $980.60M 10-K · filed 2023-02-09 | |||
| 2020-09-30 | $246.30M 10-Q · filed 2021-10-28 | $462.60M derived: sum of 2 quarters · filed 2021-10-28 | $685.50M 10-Q · filed 2021-10-28 | $893.30M derived: sum of 4 quarters · filed 2021-10-28 | |||
| 2020-06-30 | $216.30M 10-Q · filed 2021-07-29 | $439.20M 10-Q · filed 2021-07-29 | $647.00M derived: sum of 3 quarters · filed 2021-07-29 | $837.90M derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2020-03-31 | $222.90M 10-Q · filed 2021-04-29 | $430.70M derived: sum of 2 quarters · filed 2021-04-29 | $621.60M derived: sum of 3 quarters · filed 2021-04-29 | $828.90M derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2019-12-31 | $207.80M 10-K · filed 2020-02-13 | $398.70M derived: sum of 2 quarters · filed 2020-10-27 | $606.00M derived: sum of 3 quarters · filed 2020-10-27 | $789.20M 10-K · filed 2022-02-14 | |||
| 2019-09-30 | $190.90M 10-Q · filed 2020-10-27 | $398.20M derived: sum of 2 quarters · filed 2020-10-27 | $581.40M 10-Q · filed 2020-10-27 | $968.80M derived: sum of 4 quarters · filed 2020-10-27 | |||
| 2019-06-30 | $207.30M 10-Q · filed 2020-07-28 | $390.50M 10-Q · filed 2020-07-28 | $777.90M derived: sum of 3 quarters · filed 2020-07-28 | $932.60M derived: sum of 4 quarters · filed 2020-07-28 | |||
| 2019-03-31 | $183.20M 10-Q · filed 2020-04-28 | $570.60M derived: sum of 2 quarters · filed 2020-04-28 | $725.30M derived: sum of 3 quarters · filed 2020-04-28 | $883.80M derived: sum of 4 quarters · filed 2020-04-28 | |||
| 2018-12-31 | $387.40M 10-K · filed 2020-02-13 | $542.10M derived: sum of 2 quarters · filed 2020-02-13 | $700.60M derived: sum of 3 quarters · filed 2020-02-13 | $850.20M 10-K · filed 2021-02-11 | |||
| 2018-09-30 | $154.70M 10-K · filed 2020-02-13 | $313.20M derived: sum of 2 quarters · filed 2020-02-13 | $462.80M 10-Q · filed 2019-11-06 | $604.30M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $158.50M 10-K · filed 2020-02-13 | $308.10M 10-Q · filed 2019-07-31 | $449.60M derived: sum of 3 quarters · filed 2020-02-13 | $577.10M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $149.60M 10-K · filed 2020-02-13 | $291.10M derived: sum of 2 quarters · filed 2020-02-13 | $418.60M derived: sum of 3 quarters · filed 2020-02-13 | $549.70M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $141.50M 10-K · filed 2019-02-21 | $269.00M derived: sum of 2 quarters · filed 2019-02-21 | $400.10M derived: sum of 3 quarters · filed 2019-02-21 | $534.60M 10-K · filed 2020-02-13 | |||
| 2017-09-30 | $127.50M 10-K · filed 2019-02-21 | $258.60M derived: sum of 2 quarters · filed 2019-02-21 | $393.10M 10-Q · filed 2018-11-06 | $515.90M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2017-06-30 | $131.10M 10-K · filed 2019-02-21 | $265.60M 10-Q · filed 2018-08-01 | $388.40M derived: sum of 3 quarters · filed 2019-02-21 | $508.00M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2017-03-31 | $134.50M 10-K · filed 2019-02-21 | $257.30M derived: sum of 2 quarters · filed 2019-02-21 | $376.90M derived: sum of 3 quarters · filed 2019-02-21 | $482.50M derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2016-12-31 | $122.80M 10-K · filed 2018-02-27 | $242.40M derived: sum of 2 quarters · filed 2018-02-27 | $348.00M derived: sum of 3 quarters · filed 2018-02-27 | $442.30M 10-K · filed 2019-02-21 | |||
| 2016-09-30 | $119.60M 10-K · filed 2018-02-27 | $225.20M derived: sum of 2 quarters · filed 2018-02-27 | $319.50M 10-Q · filed 2017-11-01 | $409.10M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $105.60M 10-K · filed 2018-02-27 | $199.90M 10-Q · filed 2017-08-01 | $289.50M derived: sum of 3 quarters · filed 2018-02-27 | $406.60M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $94.30M 10-K · filed 2018-02-27 | $183.90M derived: sum of 2 quarters · filed 2018-02-27 | $301.00M derived: sum of 3 quarters · filed 2018-02-27 | $370.60M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $89.60M 10-K · filed 2017-02-28 | $206.70M derived: sum of 2 quarters · filed 2017-02-28 | $276.30M derived: sum of 3 quarters · filed 2017-02-28 | $335.50M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $117.10M 10-K · filed 2017-02-28 | $186.70M derived: sum of 2 quarters · filed 2017-02-28 | $245.90M 10-Q · filed 2016-11-01 | $303.70M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $69.60M 10-K · filed 2017-02-28 | $128.80M 10-Q · filed 2016-08-02 | $186.60M derived: sum of 3 quarters · filed 2017-02-28 | $238.80M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $59.20M 10-K · filed 2017-02-28 | $117.00M derived: sum of 2 quarters · filed 2017-02-28 | $169.20M derived: sum of 3 quarters · filed 2017-02-28 | $214.90M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $57.80M 10-K · filed 2016-02-23 | $110.00M derived: sum of 2 quarters · filed 2016-02-23 | $155.70M derived: sum of 3 quarters · filed 2016-02-23 | $197.80M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $52.20M 10-K · filed 2016-02-23 | $97.90M derived: sum of 2 quarters · filed 2016-02-23 | $140.00M 10-Q · filed 2015-11-04 | $176.40M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $45.70M 10-K · filed 2016-02-23 | $87.80M 10-Q · filed 2015-08-05 | $124.20M derived: sum of 3 quarters · filed 2016-02-23 | $157.60M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | $42.10M 10-K · filed 2016-02-23 | $78.50M derived: sum of 2 quarters · filed 2016-02-23 | $111.90M derived: sum of 3 quarters · filed 2016-02-23 | $143.70M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $36.40M 10-K · filed 2015-02-25 | $69.80M derived: sum of 2 quarters · filed 2015-02-25 | $101.60M derived: sum of 3 quarters · filed 2015-02-25 | $129.00M 10-K · filed 2016-02-23 | |||
| 2013-09-30 | $33.40M 10-K · filed 2015-02-25 | $65.20M derived: sum of 2 quarters · filed 2015-02-25 | $92.60M 10-Q · filed 2014-11-06 | $118.50M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $31.80M 10-K · filed 2015-02-25 | $59.20M 10-Q · filed 2014-08-06 | $85.10M derived: sum of 3 quarters · filed 2015-02-25 | $110.80M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-03-31 | $27.40M 10-K · filed 2015-02-25 | $53.30M derived: sum of 2 quarters · filed 2015-02-25 | $79.00M derived: sum of 3 quarters · filed 2015-02-25 | $104.90M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $25.90M 10-K · filed 2014-02-20 | $51.60M derived: sum of 2 quarters · filed 2014-02-20 | $77.50M derived: sum of 3 quarters · filed 2014-02-20 | $102.30M 10-K · filed 2015-02-25 | |||
| 2012-09-30 | $25.70M 10-K · filed 2014-02-20 | $25.72M 10-Q · filed 2012-11-01 | $51.60M derived: sum of 2 quarters · filed 2014-02-20 | $76.40M 10-Q · filed 2013-11-06 | $99.30M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $25.90M 10-K · filed 2014-02-20 | $25.89M 10-Q · filed 2012-08-06 | $50.70M 10-Q · filed 2013-08-07 | $50.68M 10-Q · filed 2012-08-06 | $73.60M derived: sum of 3 quarters · filed 2014-02-20 | $95.10M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-03-31 | $24.80M 10-K · filed 2014-02-20 | $24.78M 10-Q · filed 2012-05-02 | $47.70M derived: sum of 2 quarters · filed 2014-02-20 | $69.20M derived: sum of 3 quarters · filed 2014-02-20 | $88.50M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2011-12-31 | $22.90M 10-K · filed 2013-02-21 | $22.97M 10-K · filed 2012-02-23 | $44.40M derived: sum of 2 quarters · filed 2013-02-21 | $63.70M derived: sum of 3 quarters · filed 2013-02-21 | $80.70M 10-K · filed 2014-02-20 | $80.69M 10-K · filed 2012-02-23 | |
| 2011-09-30 | $21.50M 10-K · filed 2013-02-21 | $21.47M 10-Q · filed 2011-11-02 | $40.80M derived: sum of 2 quarters · filed 2013-02-21 | $57.72M 10-Q · filed 2012-11-01 | $74.67M derived: sum of 4 quarters · filed 2013-02-21 | ||
| 2011-06-30 | $19.30M 10-K · filed 2013-02-21 | $19.26M 10-Q · filed 2011-08-03 | $36.25M 10-Q · filed 2012-08-06 | $53.17M derived: sum of 3 quarters · filed 2013-02-21 | $69.71M derived: sum of 4 quarters · filed 2013-02-21 | ||
| 2011-03-31 | $17.00M 10-K · filed 2013-02-21 | $16.99M 10-K · filed 2012-02-23 | $33.88M derived: sum of 2 quarters · filed 2013-02-21 | $50.41M derived: sum of 3 quarters · filed 2013-02-21 | $66.20M derived: sum of 4 quarters · filed 2013-02-21 | ||
| 2010-12-31 | $16.88M 10-K · filed 2012-02-23 | $33.41M derived: sum of 2 quarters · filed 2012-02-23 | $49.20M derived: sum of 3 quarters · filed 2012-02-23 | $63.70M 10-K · filed 2013-02-21 | $63.73M 10-K · filed 2012-02-23 | ||
| 2010-09-30 | $16.54M 10-K · filed 2012-02-23 | $32.33M derived: sum of 2 quarters · filed 2012-02-23 | $46.86M 10-Q · filed 2011-11-02 | ||||
| 2010-06-30 | $15.79M 10-K · filed 2012-02-23 | $30.32M 10-Q · filed 2011-08-03 | |||||
| 2010-03-31 | $14.53M 10-K · filed 2012-02-23 | ||||||
| 2009-12-31 | $49.49M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |